Symptomatic Treatment for Herpangina in Adults
For symptomatic treatment of herpangina in adults, use topical analgesics/anesthetics (such as benzydamine spray) combined with systemic analgesics (NSAIDs or acetaminophen), adequate hydration, and dietary modifications to avoid irritating foods.
Core Symptomatic Management
The treatment of herpangina is primarily symptomatic, as this enterovirus infection is self-limiting with a typical course of 4-6 days 1. The following approach addresses pain control and supportive care:
Pain Management
- Topical therapy: Benzydamine spray (0.255 mg/dose, 6 doses 3 times daily) provides local anesthetic effect and reduces pharyngeal pain 2
- Systemic analgesics: NSAIDs (ibuprofen) or acetaminophen for fever and pain control 3
- Topical anesthetics: OTC topical anesthetic agents can be used, though evidence for their effectiveness is limited 4
Supportive Care Measures
- Adequate rehydration: Critical given painful swallowing may reduce oral intake 2
- Dietary modifications:
- Exclude salty, spicy, and fried foods that irritate oral lesions 2
- Soft, bland, cool foods are better tolerated
- Activity restrictions: Limit physical activity during acute phase 2
- Avoid thermal procedures: No hot compresses or heat application 2
Important Clinical Caveats
Distinguish from herpes simplex virus (HSV) gingivostomatitis: While both present with oral lesions, herpangina typically affects the posterior pharynx (soft palate, uvula, tonsillar pillars) and is caused by enteroviruses (Coxsackievirus A, Enterovirus A, Echovirus), whereas HSV affects anterior oral structures and gingiva 1, 5. This distinction matters because HSV may warrant antiviral therapy with acyclovir, while herpangina does not respond to anti-HSV antivirals.
Antiviral considerations: The evidence provided focuses on herpes labialis (HSV), not herpangina 4. Oral acyclovir is mentioned for herpetic gingivostomatitis but is NOT indicated for enteroviral herpangina. One case report mentions inosine pranobex (Groprinosin) at 50 mg/kg daily for 7 days 2, but this is not standard evidence-based therapy and lacks robust supporting data for routine use.
Expected Course and Red Flags
- Natural history: Complete resolution typically occurs within 7-10 days 2, 6
- Monitor for complications: While rare in immunocompetent adults, watch for dehydration from poor oral intake
- Prognosis: Generally excellent with symptomatic management alone 1
The key to effective management is early initiation of pain control to maintain adequate hydration and nutrition during the brief symptomatic period.